Feb 27 (Reuters) - Aardvark Therapeutics (AARD.O), opens new tab is voluntarily pausing its late-stage trial testing its experimental treatment for a type of rare genetic disease after it found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results